This is rather an interesting site regarding awards for progress in anti aging medicine.
Sponsored by The Glenn Foundation for Medical Research, in collaboration with the American Federation for Aging Research (AFAR), the "Breakthroughs in Gerontology" (BIG) initiative provides timely support to a small number of pilot research programs that may be of relatively high risk but which offer significant promise of yielding transforming discoveries in the fundamental biology of aging. The hope is that one or more of the funded research projects will lead to major new insights into the molecular factors that coordinate aging in multiple cells and tissues, and the ways in which the aging process is differentially timed in long-lived species.
Projects that focus on genetic controls of aging and longevity, on delay of aging by pharmacological agents or dietary means, or which elucidate the mechanisms by which alterations in hormones, anti-oxidant defenses, or repair processes promote longevity are all within the intended scope of this competition. Projects that focus on specific diseases or assessment of health care strategies will receive lower priority, unless the research plan makes clear and direct connections to fundamental issues in the biology of aging. Studies of invertebrates, mice, human clinical materials or cell lines are eligible for funding.
The site is at http://www.afar.org/GlennBIG.html
No comments:
Post a Comment